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Edited by Richard MaraisAbstract We investigated the mechanism whereby cell contact
injury stimulates the a-smooth muscle actin (SMA) promoter,
a key process for epithelial–mesenchymal transition (EMT) dur-
ing organ ﬁbrosis. Contact disruption by low-Ca2+ medium
(LCM) activated Rac, PAK and p38 MAPK, and triggered
the nuclear accumulation of myocardin-related transcription fac-
tor (MRTF), an inducer of the SMA promoter. Dominant nega-
tive (DN) Rac, DN-PAK, DN-p38, or the p38 inhibitor
SB203580 suppressed the LCM-induced nuclear accumulation
of MRTF and the activation of the SMA promoter. These stud-
ies deﬁne novel pathway(s) involving Rac, PAK, and p38 in the
regulation of MRTF and the contact-dependent induction of
EMT.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Myocardin and myocardin-related transcription factors
(MRTFs, also known as MALs, MKLs) are coactivators of
serum response factor (SRF) a key regulator of cell growth,
diﬀerentiation and muscle-speciﬁc gene expression [1–3]. The
recent discovery of MRTFs greatly promoted our understand-Abbreviations: CA, constitutively active; DN, dominant negative;
EMT, epithelial–mesenchymal transition; LCM, low-Ca2+ medium;
MLC, myosin light chain; MRTF, myocardin-related transcription
factor; PAK, p21-activated kinase; PBD, p21 binding domain; ROK,
Rho kinase; SFM, serum-free medium; SMA, a-smooth muscle actin;
YFP, yellow ﬂuorescent protein
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doi:10.1016/j.febslet.2007.12.021ing of two old enigmas of muscle diﬀerentiation [4,5]. First, the
regulation of MRTF explained how SRF, a ubiquitously
expressed protein, is able to control growth in a variety of tis-
sues, while it induces muscle-speciﬁc gene expression only in a
narrow subset (muscle cells, ﬁbroblasts). Second, it has been
long known that the cytoskeleton, and particularly actin poly-
merization, regulates muscle gene expression [6], but only re-
cent studies have identiﬁed MRTF as the cytoskeleton-
dependent element in this process. In ﬁbroblasts, under resting
conditions monomeric (G) actin binds to the RPEL motif at
the N-terminus of MRTF and this prevents the nuclear trans-
location of MRTF. When myogenic stimuli induce F-actin
polymerization, G-actin dissociates from MRTF, which then
translocates to the nucleus and activates SRF [7].
Epithelial–mesenchymal transition (EMT), a key process in
organ development and cancer, has recently emerged as an
important pathomechanism in organ ﬁbrosis [8–10]. Exposed
to ﬁbrogenic stimuli, such as TGF-b1, a variety of epithelial
cells transform into ﬁbroblasts, and ultimately to myoﬁbro-
blasts (MFs), which express smooth muscle a-actin (SMA), a
hallmark of this phenotype. MFs play a crucial role in the pro-
gression of ﬁbrosis [10]. Our recent studies have shown that in
kidney tubular (LLC-PK1) cells TGF-b1 alone is insuﬃcient to
provoke this myogenic transformation; the other prerequisite
is an injury or absence of intercellular junctions, which can
be modeled by scratch wounding the monolayer or by disrupt-
ing the Ca2+-dependent contacts using low-Ca2+ medium
[11,12]. Using this powerful model system, we have shown that
cell contact disruption activates the SMA promoter by induc-
ing the translocation of MRTF into the nucleus. Investigating
the underlying mechanisms we found that the contact injury-
induced activation of the Rho/Rho kinase pathway, and the
ensuing myosin light chain (MLC) phosphorylation contrib-
uted to this eﬀect [12]. Since, in addition to RhoA, Rac, an-
other member of the Rho family, is also involved in the
regulation of intercellular contacts [13], and it shares several
common downstream eﬀects with Rho on the cytoskeleton
(e.g. actin polymerization, coﬁlin and MLC phosphorylation)
[14], we asked whether this small GTPase also participates in
the contact-dependent regulation of myogenic transformation.
Our results show that Rac, its downstream eﬀector PAK, and
the activation of p38 MAP kinase are indispensable forblished by Elsevier B.V. All rights reserved.
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activation of the SMA promoter, and thus ultimately for
EMT.2. Materials and methods
2.1. Materials and reagents
All reagents were from Sigma (St. Louis, MO) if not otherwise sta-
ted. Jasplakinolide, Y-27632 and SB203580 were from Calbiochem (La
Jolla, CA). The following antibodies were used: Rac (Upstate Biotech-
nology, Lake Placid, NY), Hsp27 (Stressgen, Victoria, BC), Myc (9E-
10), Cdc42 and p38 (Santa Cruz Biotechnology, Santa Cruz, CA);
phospho-coﬁlin, coﬁlin, monophospho-MLC, phospho-Hsp27(Ser82),
phospho-p38(Thr180/Tyr182) and phospho-PAK1(Thr423)/
PAK2(Thr402) (Cell Signaling Technology, Danvers, MA); histones
(Chemicon, Temecula, CA) and tubulin (Sigma). The polyclonal
anti-BSAC raised against the mouse MKL1 protein was described pre-
viously [15]. Secondary antibodies were from Jackson ImmunoRe-
search Laboratories (West Grove, PA).2.2. Cell culture and treatments
LLC-PK1/AT1 cells, a kind gift of Dr. R.C. Harris (Vanderbilt Uni-
versity School of Medicine, Nashville, TN) were used as in our previ-
ous studies [12]. For Ca2+ deprivation, after washing with phosphate-
buﬀered saline (Gibco), cells were incubated in serum- and CaCl2-free
DMEM (low-Ca2+ medium, LCM, Gibco). Control samples were
incubated with serum-free DMEM containing Ca2+ (SFM).
2.3. Plasmids and transfection
pSMA-Luc containing the 765 bp portion of the rat SMA promoter
was a kind gift from Dr. R.A. Nemenoﬀ [16]. Constitutively active
myc-tagged Rac (CA-Rac, Rac1Q61L) and dominant negative (DN)
Rac (Rac1T17N) were described previously [17]. Myc-tagged PAK1
mutants (CA-PAK: PAK1H83,86L/T422E and DN-PAK:
PAK1H83,86L/K299R) were from Dr. A.S. Mak [18]. YFP-tagged
p21 binding domain (PBD) of PAK1 was a kind gift from Dr. Sergio
Grinstein (The Hospital for Sick Children, Toronto, ON, Canada).
The DN-p38 construct (p38aT180A/Y182F) was kindly provided by
Dr. A. Klip (The Hospital for Sick Children, Toronto, ON, Canada)
[19]. For promoter studies cells on 6-well plates were co-transfected
with 0.5 lg pSMA-Luc, 0.05 lg pRL-TK internal control (Promega,
Madison, WI) and 2 lg of the corresponding vector using FuGENE6
(Roche Laval, QC, Canada) as described [11]. Fireﬂy and Renilla lucif-
erase activities were measured with the Dual Luciferase Reporter As-
say System (Promega) using a Berthold Lumat LB 9507 luminometer
(Bad Wildbad, Germany). Results are expressed as fold increase over
pcDNA3 controls in SFM showing the scatter within each experiment
(mean ± S.E., n P 6). For immunoﬂuorescence microscopy, cells on
glass coverslips were transfected with 2 lg expression vector 48 h prior
to the experiments.
2.4. Immunoﬂuorescence microscopy
Immunostaining of conﬂuent LLC-PK1 cells was performed as de-
scribed [12]. Samples were viewed using an Olympus IX81 microscope
(Melville, NY) coupled to an Evolution QEi Monochrome camera
(Media Cybernetics, Silver Spring, MD). For detecting in vivo Rac
activity cells were transfected with PBD-YFP 2 days prior to the treat-
ment. Loci of Rac activation were monitored using a Leica DMIRE2
inverted ﬂuorescence microscope equipped with a Hamamatsu Back-
Thinned EM-CCD camera and spinning disk confocal scan head.
2.5. Rac and Cdc42 activity assays and Western blotting
Active small G-proteins were captured with PAK p21-binding-do-
main (PBD)-GST fusion protein using a Rac activation Kit (Upstate
Biotechnology). Western blotting and densitometry were performed
as described [12].
2.6. Nuclear extraction
Nuclear extracts were prepared as in [12] using the NE-PER Kit
from Pierce Biotechnology (Rockford, IL). Equal amounts (10 lg) of
nuclear extracts were analyzed by Western blotting.3. Results
3.1. Rac and PAK are stimulated by contact disassembly and
contribute to the injury-dependent activation of the SMA
promoter and MRTF translocation
To assess the potential role of Rac and Cdc42 in the cell con-
tact-dependent regulation of the SMA promoter, initially we
tested the eﬀect of Ca2+ removal-triggered contact disassembly
on these GTPases using an aﬃnity pull-down assay that pre-
cipitates their active (GTP-bound) form. Exchanging the ser-
um-free medium (SFM) to a low-Ca2+ medium (LCM)
induced a sizable activation of Rac and Cdc42 that continued
to increase up to 30 min (Fig. 1A and B). To substantiate this
ﬁnding and localize Rac activation, we performed live confocal
video-imaging on LLC-PK1 cells transfected with YFP-p21-
binding domain (PBD) of p21-activated kinase (PAK). Ca2+
removal caused strong peripheral accumulation of YFP-PBD
within a few minutes (Fig. 1C), which was most prominent
in cells with moderate YFP-PBD expression and deﬁnitive
contact disassembly. To assess whether Rac/Cdc42 activation
translates into downstream signaling events, we investigated
the eﬀect of contact disassembly on PAK phosphorylation.
LCM facilitated rapid and sustained PAK1 phosphorylation
(Fig. 1D). Next we examined the functional signiﬁcance of
Rac and PAK activation in the regulation of the SMA pro-
moter, a key target for myoﬁbroblast transition. Cells were
transfected with the pSMA-Luc reporter system along with
either an empty vector or constitutively active (CA) or domi-
nant negative (DN) mutants of Rac and PAK. CA-Rac as well
as CA-PAK stimulated the SMA promoter (Fig. 1E), consis-
tent with the SRF-activating capacity of CA-Rac [20]. Impor-
tantly, both DN-Rac and DN-PAK potently inhibited the
LCM-triggered promoter activation (Fig. 1E).
Since MRTF is a cytoskeleton-regulated cofactor essential
for the activation of SRF-dependent genes, including SMA
[1,3], we asked whether Rac and/or PAK impacts on MRTF
localization. Similar to Ca2+ removal (Fig. 2A and [12]), CA-
Rac and CA-PAK induced nuclear translocation of MRTF
(Fig. 2B). Importantly, DN-Rac and DN-PAK substantially
reduced the LCM-induced nuclear accumulation of MRTF
(Fig. 2B and C). Together these ﬁndings imply that contact in-
jury not only activates Rac and PAK, but their activation con-
tributes to the nuclear translocation or retention of MRTF
and the ensuing SMA promoter activation.3.2. Rac and PAK do not act on MRTF via modifying coﬁlin or
MLC phosphorylation
Previous studies have implicated Rho as the primary regula-
tor of MRTF localization, via its eﬀects on the actin skeleton.
Rho acts on actin by two major pathways: it activates mDia,
leading to polymerization, and induces Rho kinase (ROK)-
mediated coﬁlin phosphorylation, which reduces F-actin sever-
ing [14]. Additionally, we have shown that ROK-dependent
MLC phosphorylation plays a permissive role in MRTF trans-
location [12]. Since both coﬁlin and MLC phosphorylation
may also be downstream of the Rac/PAK pathway (reviewed
in [14,21]), we considered that Rac might act via contributing
to these eﬀects. Indeed, LCM increased coﬁlin phosphoryla-
tion (Fig. 3A and C). However, DN-Rac and DN-PAK
failed to aﬀect coﬁlin phosphorylation (Fig. 3B). Since we
have shown that LCM rapidly activates Rho as well [12], we
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Fig. 1. Rac/Cdc42 and PAK are activated by contact disassembly and contribute to the ensuing activation of the SMA promoter. (A) Conﬂuent
LLC-PK1 cells were serum-deprived and either incubated in SFM or LCM for the indicated times. Active Rac/Cdc42 was captured by PBD-GST
beads. (B) Densitometric analysis of Rac activation is expressed as fold increase over control (mean ± S.E., n = 3). (C) Cells were transfected with
PBD-YFP and treated with LCM. Images of the transfected cells (within a conﬂuent monolayer) were taken at the indicated times. (D) Active PAK1
was detected by a phospho-speciﬁc antibody. (E) Cells were cotransfected with pSMA-Luc and pRL-TK plasmid along with either empty vector
(Control) or with one of the test plasmids, as indicated. Cells were incubated in SFM or LCM, and 24 h later luciferase assays were performed.
A. Sebe et al. / FEBS Letters 582 (2008) 291–298 293considered whether this is the critical stimulus for coﬁlin phos-
phorylation. Indeed, the ROK inhibitor Y-27632 abolished
this response (Fig. 3C and D), and also prevented the nuclear
translocation of MRTF (Fig. 3E and F). These data indicate
that Rac activation is neither suﬃcient nor necessary for coﬁlin
phosphorylation. Further, although CA-Rac or CA-PAK pro-
voked MLC phosphorylation, DN-Rac or DN-PAK did not
eliminate the LCM-induced response (not shown). We there-
fore concluded that other mechanisms must be responsible
for the Rac/PAK-mediated regulation of MRTF.3.3. p38 is activated by contact injury and plays an essential role
in the nuclear accumulation and activity of MRTF
Since p38 is a potential target of Rac [22], and has been
implicated in SMA expression [16], we examined its involve-
ment in the contact-dependent responses. LCM induced rapid
phosphorylation of p38 as well as heat shock protein 27(Hsp27) (Fig. 4A and B), a downstream target of p38 and reg-
ulator of the actin skeleton. The latter eﬀect was blocked by
the speciﬁc p38 inhibitor, SB203580 (Fig. 4B). More impor-
tantly, SB203580 or the expression of a DN-p38 strongly re-
duced the contact disruption-triggered activation of the SMA
promoter (Fig. 4C). Next we tested whether this eﬀect might
be related to altered nucleocytoplasmic traﬃc of MRTF. Inhi-
bition of p38 dramatically reduced the LCM-provoked nuclear
accumulation of MRTF, as revealed by immunoblots per-
formed on nuclear fractions or by immunoﬂuorescence micros-
copy (Fig. 4D–F). In agreement with our previous results
scratch-wounding of the epithelium also promoted nuclear
accumulation of MRTF [12], and inhibition of p38 suppressed
this eﬀect as well (Fig. 4F). During these experiments we noted
that LCM induced an upward shift in the molecular mass of
MRTF. Nuclei isolated from stimulated cells contained pre-
dominantly the higher Mw species. SB203580 nearly abolished
this shift (Fig. 4G).
DN-Rac DN-PAKNon
0
100
80
60
40
20
MRTF distribution
Cytoplasmic
Homogenous
Nuclear
M
R
TF
1 h 2  h 6 h
Low Calcium
DN-Rac
Low Calcium
DN-PAK
Low Calcium
M
R
TF
M
yc
CA-Rac
With Calcium
CA-PAK
With Calcium
C
el
ls
 (%
)
Control
Control
Low Calcium
n=463 n=916 n=241 n=190
Fig. 2. Rac and PAK participate in the contact disassembly-induced nuclear translocation of MRTF. (A) Cells were stimulated with LCM for the
indicated times and the localization of endogenous MRTF was visualized by immunostaining. (B) Cells transfected with Myc-tagged CA-Rac, CA-
PAK, DN-Rac or DN-PAK, were treated with SFM or LCM for 1 h, and then doubly stained for MRTF (red) and Myc (green). Arrows indicate
identical transfected cells. (C) MRTF localization (cytoplasmic, homogeneous, and nuclear) was quantiﬁed as in Ref. [12].
294 A. Sebe et al. / FEBS Letters 582 (2008) 291–298While Rac, PAK and p38 might constitute consecutive ele-
ments of the same signaling pathway, each can be activated
by multiple mechanisms and can exert independent down-
stream eﬀects, particularly on the cytoskeleton. To assess
whether PAK and p38 are – at least partially – downstream
to Rac activation in MRTF regulation, we transfected cells
with CA-Rac along with DN-PAK or DN-p38. These DN
constructs signiﬁcantly reduced (but did not abolish) the CA-
Rac-induced activation of the SMA promoter (Fig. 5A).
Accordingly, inhibition of PAK or p38 mitigated the CA-
Rac-induced nuclear accumulation of MRTF (Fig. 5C andD). While p38 plays an important role in the contact injury-
provoked SMA promoter activation, we considered that ro-
bust actin polymerization might be suﬃcient for this eﬀect,
even in the absence of the facilitating impact of p38. Indeed,
the dramatic activation of the SMA promoter by the F-ac-
tin-polymerizing drug jasplakinolide was not aﬀected by p38
inhibition (Fig. 5B).
Taken together, p38 activation (in addition to Rho signal-
ing) is an essential input in the injury-induced nuclear traﬃc
of MRTF, and may be one of the mediators of the impact of
Rac on this process.
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The present study deﬁnes novel mechanisms, involving Rac,
PAK and p38, in the cell contact-dependent regulation of
MRTF, and provides new insights into mechanisms through
which the injury of the intercellular junctions facilities EMT.
Our ﬁnding that Rac is activated upon contact disassembly
may seem somewhat unexpected, inasmuch as earlier studies re-
ported a decrease in Rac activity upon the addition of the Ca2+-
chelator EGTA to epithelial cells [23,24]. However, we observed
that prolonged (30 min) EGTA treatment caused blebbing in
many cells, while LCM did not exert any obvious toxic eﬀect.
Moreover, novel ﬁndings give credence to a contact disassem-
bly-induced Rac-activating mechanism. First, Rap is stimulatedby contact disruption, and this small GTPase has been placed
upstream of Rac [24]. Further, the GDP/GTP exchange factor
GEF-H1 that has recently been identiﬁed as the activator of
Rho upon contact disassembly [25], can also act as a Rac-
GEF [26]. Moreover, PAK activation, was proposed to facilitate
the Rac-activating potency of GEF-H1 [27]. Thus, PAK activa-
tion, either downstream or independent of Rac may represent a
positive feedback mechanism. In any case, our results show that
acute contact injury leads to both Rho [12] and Rac activation,
and each of these is indispensable for the ensuing activation of
the SMA promoter. Although the injury-induced activation of
small GTPases is transient, this initial response is required for
full-blown EMT that develops over several days in the presence
of contact disruption and TGF-b1 [12].
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296 A. Sebe et al. / FEBS Letters 582 (2008) 291–298One of the central ﬁndings of this study is that p38 is an
important regulator of MRTF localization and activity. Con-
tact disruption activated p38 in epithelial cells, and this process
was necessary both for the shift in the Mw of MRTF, and its
accumulation and action in the nucleus. Our data suggest that
p38 might act, at least partially, downstream of Rac and PAK.
Nonetheless, both Rac and PAK are known to induce F-actinpolymerization, which can facilitate MRTF translocation
without p38. We propose that p38 might regulate the G-actin
aﬃnity of MRTF (and/or enhance Hsp27-mediated actin poly-
merization), thereby facilitating the combinatorial eﬀect of
other F-actin-polymerizing inputs.
In a landmark paper, Miralles et al. [7] reported that serum
stimulation of ﬁbroblasts led to a shift in the Mw of MRTF.
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sensitive to the inhibition of ROK and ERK. We propose a
critical role for p38 in the modiﬁcation and traﬃc of MRTF.
It remains to be clariﬁed whether p38 mediates direct or indi-
rect phosphorylation of MRTF, and whether this occurs in the
cytosol or in the nucleus. While impaired nuclear accumulation
of MRTF apparently argues for a cytosolic eﬀect, this is not
necessarily so; MRTF has recently been reported to rapidly
shuttle between the cytosol and the nucleus, and a reduction
in its rate-limiting eﬄux was proposed to be the primary mech-
anism of regulation [28]. p38 may be necessary for increased
inﬂux or reduced eﬄux and/or enhanced interaction of MRTF
with its intranuclear partners (e.g. SRF). It will be interesting
to deﬁne, whether p38 facilities the dissociation of actin from
MRTF in the cytosol (necessary for inﬂux) and/or prevents
its association with actin in the nucleus (proposed to be neces-
sary for eﬄux [28]). p38, being a general stress kinase, may link
various stress conditions to MRTF regulation. While p38 acti-
vation facilitates MRTF nuclear accumulation, our prelimin-
ary data suggest that it is not suﬃcient. Future studies
should deﬁne the exact molecular mechanism whereby this ma-
jor stress kinase contributes to the regulation of MRTF, a key
transcription factor for myogenic diﬀerentiation and epithe-
lial–myoﬁbroblast transition.Acknowledgements: This work was supported by grants from the Kid-
ney Foundation of Canada (A.K. and K.S.), NSERC (A.K.) a Pre-
miers Research Excellence Award to A.K. and a KRESCENT New
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